Teachers Retirement System of The State of Kentucky Purchases 24,452 Shares of Encompass Health Corporation $EHC

Teachers Retirement System of The State of Kentucky lifted its position in shares of Encompass Health Corporation (NYSE:EHC) by 82.9% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 53,963 shares of the company’s stock after acquiring an additional 24,452 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Encompass Health were worth $5,219,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Price T Rowe Associates Inc. MD boosted its holdings in Encompass Health by 24.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock valued at $510,047,000 after acquiring an additional 948,202 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after purchasing an additional 3,793,358 shares during the period. Wellington Management Group LLP boosted its stake in shares of Encompass Health by 21.7% in the 4th quarter. Wellington Management Group LLP now owns 3,384,877 shares of the company’s stock valued at $359,271,000 after purchasing an additional 603,472 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in shares of Encompass Health by 27.2% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,722,887 shares of the company’s stock valued at $289,008,000 after purchasing an additional 581,812 shares during the last quarter. Finally, Alliancebernstein L.P. grew its position in shares of Encompass Health by 6.8% during the 2nd quarter. Alliancebernstein L.P. now owns 2,039,314 shares of the company’s stock worth $250,081,000 after buying an additional 129,276 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. TD Cowen began coverage on shares of Encompass Health in a report on Thursday, May 28th. They issued a “buy” rating and a $125.00 price objective on the stock. Leerink Partners set a $152.00 target price on shares of Encompass Health in a report on Friday, May 22nd. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Barclays cut their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. Finally, Weiss Ratings cut Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $143.86.

Insiders Place Their Bets

In related news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.80% of the stock is currently owned by corporate insiders.

Encompass Health Stock Performance

Shares of EHC opened at $108.97 on Wednesday. The firm has a market cap of $10.81 billion, a P/E ratio of 18.19, a PEG ratio of 2.40 and a beta of 0.74. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. The firm’s 50 day moving average price is $104.15 and its two-hundred day moving average price is $103.51.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.51 by $0.09. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter in the prior year, the firm earned $1.37 earnings per share. The firm’s revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, analysts forecast that Encompass Health Corporation will post 5.97 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.19 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 12.69%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.